At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
Pancreatic fully-covered self-expanding metal stent (FCSEMS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fully Covered Self Expanding Metal Stents (FCSEMS) for Pancreatic Duct Strictures in Patients With Chronic Pancreatitis
In Brief
A clinical study evaluating Pancreatic fully-covered self-expanding metal stent (FCSEMS) for Chronic Pancreatitis. Completed, enrolled 67 participants across 11 sites in 6 countries.
Detailed Summary
To prospectively document the performance of a FCSEMS for treatment of pancreatic duct strictures in patients with painful chronic pancreatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pancreatitis
CountriesBelgium, Canada, India, Italy, Netherlands, United States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJan 2017
Primary CompletionNov 2021
TodayJul 2026
First PostedJun 16, 2016
Enrollment StartJan 25, 2017
Primary CompletionNov 24, 2021
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 10.0 years ago
Interventions
Pancreatic fully-covered self-expanding metal stent (FCSEMS)device
The WallFlex™ Pancreatic RX Fully Covered Soft Stent System consists of a flexible delivery system preloaded with a self-expanding pancreatic metal stent.